Oxymetazoline Hydrochloride
Home / API - Commercial / Oxymetazoline Hydrochloride
CAS No.
2315-02-8
Therapeutic Category
- Topical Nasopharyngeal
Innovator Brand
NASIVIN , AFRIN , ILIADIN
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Oxymetazoline is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. Ophthalmic oxymetazoline is indicated for the treatment of acquired blepharoptosis in adults.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.